JUNAID ALI
Srinagar, 04 April 2026: Medanta– The Medicity in Gurugram, held a press conference in Srinagar on Saturday, led by Director-Neurosurgery, Dr. Anirban Deep Banerjee. Explaining the procedure, Dr. Anirban Deep Banerjee, Director-Neurosurgery at the Institute of Neurosciences, Medanta, said, “DBS or Brain Pacemaker Surgery is a transformative therapy wherein electrodes are implanted in specific affected areas of the brain to regulate abnormal signals, restoring motor function, and greatly enhancing quality of life. It is known to bring relief to advanced-stage symptoms of Parkinson’s disease, dystonia, epilepsy (adult onset), essential tremor, and obsessive-compulsive disorder (OCD).”
This technology uses tiny implanted electrodes to read brain signals and understand how the brain is functioning. By correlating these signals with a patient’s symptoms, doctors gain clear, measurable insights that help fine-tune DBS therapy more precisely, resulting in better and more consistent symptom control over time.
Highlighting the growing burden of neurological disorders in India, Dr. Anirban Deep Banerjee, Director-Neurosurgery at the Institute of Neurosciences, Medanta, said, “Neurological conditions are among the leading causes of disability worldwide and account for nearly 10% of our country’s total disease burden. While advanced treatments like DBS can significantly improve patient outcomes, access to such therapies remains a key challenge.”
Despite the availability of effective treatments, awareness and access remain limited. At Medanta, DBS therapy has already transformed the lives of hundreds of patients, including Jammu resident Mrs. Harmeet Kour and Mr. Gandharv Chand from Udhampur.
